Autonomix Medical (NASDAQ:AMIX) vs. iRadimed (NASDAQ:IRMD) Head to Head Analysis

Autonomix Medical (NASDAQ:AMIX) and iRadimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Earnings and Valuation

This table compares Autonomix Medical and iRadimed”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41 million	($5.74)	-0.18
iRadimed	$77.64 million	12.58	$19.23 million	$1.62	47.41

iRadimed has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Autonomix Medical and iRadimed, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1	1	1	0	2.00
iRadimed	0	0	2	0	3.00

Autonomix Medical currently has a consensus target price of $5.00, suggesting a potential upside of 385.44%. iRadimed has a consensus target price of $81.00, suggesting a potential upside of 5.46%. Given Autonomix Medical’s higher possible upside, equities research analysts clearly believe Autonomix Medical is more favorable than iRadimed.

Volatility & Risk

Autonomix Medical has a beta of -2.8, suggesting that its stock price is 380% less volatile than the S&P 500. Comparatively, iRadimed has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Profitability

This table compares Autonomix Medical and iRadimed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-172.93%	-133.39%
iRadimed	26.61%	23.30%	20.62%

Institutional & Insider Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 92.3% of iRadimed shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 36.8% of iRadimed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

iRadimed beats Autonomix Medical on 12 of the 13 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.